Survivors’ Plasma Still a Solid Option for Treating COVID-19, Experts Say
WEDNESDAY, Aug. 26, 2020 (HealthDay News) — Despite the wave of criticism that has followed the U.S. Food and Drug Administration’s emergency approval of convalescent plasma to treat COVID-19 patients, infectious disease experts say the therapy remains promising. Some scientists have questioned both the timing of the approval and theContinue Reading







